According to a Massachussetts General Hospital press release this is one of the only institutes in the world to integrate cardiovascular and cerebrovascular care. The Mass General Institute for Heart, Vascular and Stroke Care delivers leading research and comprehensive clinical care to advance the diagnosis and treatment of cardiovascular and cerebrovascular disease. By matching each patient with the right specialist working in a multidisciplinary team, the Mass General Institute for Heart, Vascular and Stroke Care pioneers a patient- and disease-focused care model.
El uso de la cirugía mínimamente invasiva para evacuar los hematomas residuales de una hemorragia intracerebral (HIC), con o sin un activador del plasminógeno tisular recombinante (rtPA), reduce el edema peri hematoma, según revela el estudio MISTIE II publicado en Stroke y presentado en la Conferencia Internacional de ACV 2013, Honolulu, Hawái.
El daño en unos minúsculos vasos sanguíneos del cerebro podría ser un factor contribuyente secundario a la enfermedad de Alzheimer, sugiere un nuevo estudio de tamaño reducido.
An independent, prospective, randomized study of patients with vertebral compression fractures (VCFs) comparing the effectiveness of balloon kyphoplasty with the Kiva VCF Treatment System by Benvenue Medical, Inc. found that only the Kiva system significantly restored vertebral body wedge deformity, Gardner angle. The Kiva system also resulted in significantly lower rates of extravasation and cement volume than balloon kyphoplasty. The peer-reviewed study results were published online and in the Feb. 15 edition of Spine
MRI Interventions, Inc. (MRIC) announced today that the company ended 2012 having achieved the 20th installation of its ClearPoint(R) Neuro Intervention System. ClearPoint systems are in clinical use with MRI scanners from the three major manufacturers, Siemens, GE Healthcare and Philips Healthcare, as well as the two major interventional MR/OR platforms that are manufactured by IMRIS and Brainlab
Two studies published in the Journal of Endovascular Therapy have concluded that the use of drug-eluting balloons to treat in-stent restenosis after carotid artery stenting shows promising preliminary results. The investigations describe for the first time the off-label utilisation of drug-eluting balloons for treatment of extracranial carotid in-stent restenosis.
Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR revascularization device in the treatment of acute ischemic stroke.
The Penumbra 5MAX DDC and 4MAX DDC distal delivery catheters are new devices designed to simplify delivery of a wide variety of endovascular therapies to the brain. The DDC family delivers exceptional distal delivery capability via a novel advanced polymer and nitinol coil reinforcement design at the distal tip to enable easy tracking through tortuous vessels. All DDC catheters have large tapered lumens, which are compatible with most microcatheter-delivered neuro endovascular therapies today. The DDC exclusive tapered lumen design enables higher contrast flow and better visualization while maintaining the flexibility to help physicians deliver therapies more efficiently
Un metaanálisis de la literatura médica revela que los desviadores de flujo sanguíneo son un tratamiento efectivo de los aneurismas intracraneales graves, pero tienen el riesgo de varias complicaciones, en especial si se trata de aneurismas cerebrales posteriores.
Un estudio preliminar realizado en un centro de investigación de Gran Bretaña arrojó una evolución positiva en los pacientes que se despertaron con síntomas de un accidente cerebrovascular (ACV) tras haber sido tratados con trombolisis.
PHILADELPHIA--(Healthcare Sales & Marketing Network)--InfraScan, a medical device company specializing in brain injury diagnostic products, announced today that it has obtained U.S. Food and Drug Administration approval to market the Infrascanner™ Model 2000, a noninvasive handheld brain hematoma detector.
Covidien ($COV) may have U.S. and regulatory approvals in place for its Solitaire FR, a clot-retrieval device meant to restore blood flow to the brain for patients with acute ischemic strokes. But the company is plowing ahead with a large post-approval study to gather more data on treatment and outcomes.
Takahisa Mori, Shonan Kamakura General Hospital Stroke Center, Kamakura City, Kanagawa, Japan, and colleagues reported on their first experience of transbrachial carotid artery stenting using a novel sheath guide in the Journal of NeuroInterventional Surgery.
A study, published in the Journal of NeuroInterventional Surgery and conducted by Brijesh P Mehta, Division of Neurointerventional Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA, and colleagues, has assessed the variability in neurointerventional practice for intra-arterial therapy with tPA for patients with major acute ischaemic stroke secondary to large vessel occlusions.
Covidien has announced the launch of a new study SWIFT PRIME (Solitaire FR as primary treatment for acute ischaemic stroke), which has enrolled its first patient at the University at Buffalo, USA. The new multicentre, randomised controlled trial will be one of the largest global studies to examine the adjunctive use of mechanical thrombectomy during the early stages of acute ischaemic stroke onset.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos